These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 31277739

  • 1. MicroRNAs as Biomarkers for Germ Cell Tumors.
    Nappi L, Nichols C.
    Urol Clin North Am; 2019 Aug; 46(3):449-457. PubMed ID: 31277739
    [Abstract] [Full Text] [Related]

  • 2. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A.
    J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
    [Abstract] [Full Text] [Related]

  • 3. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ.
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [Abstract] [Full Text] [Related]

  • 4. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
    Rijlaarsdam MA, van Agthoven T, Gillis AJ, Patel S, Hayashibara K, Lee KY, Looijenga LH.
    Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The present and future of serum diagnostic tests for testicular germ cell tumours.
    Murray MJ, Huddart RA, Coleman N.
    Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Testicular cancer: risk stratification in adolescents with nonseminoma.
    Looijenga LH.
    Nat Rev Urol; 2014 Jul; 11(7):367-8. PubMed ID: 24960597
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP.
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [Abstract] [Full Text] [Related]

  • 12. Current Clinical Applications of Testicular Cancer Biomarkers.
    Mir MC, Pavan N, Gonzalgo ML.
    Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
    [Abstract] [Full Text] [Related]

  • 13. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
    Raghavan D, Boyer M.
    Prog Clin Biol Res; 1990 Feb; 350():309-18. PubMed ID: 2166960
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of Clinical Stage I Germ Cell Tumors.
    Roth BJ.
    Urol Clin North Am; 2019 Aug; 46(3):353-362. PubMed ID: 31277730
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.